This is a StreetInsider.com Premium Only Page

FibroGen (FGEN) –

Apr 9, 2021 03:59 AM Increasing unusual call option volume: FGEN BOX ASO PLNT VIAC

Apr 7, 2021 09:29 AM Pre-Open Stock Movers 04/07: (SOS) (NMTR) (UTME) Higher; (FGEN) (GEO) (FIXX) Lower (more...)

Apr 7, 2021 08:31 AM Form 8-K FIBROGEN INC For: Apr 06

Apr 7, 2021 07:49 AM FibroGen (FGEN) PT Lowered to $55 at Stifel

Apr 7, 2021 06:30 AM Mizuho Securities Downgrades FibroGen (FGEN) to Neutral

Apr 7, 2021 06:11 AM H.C. Wainwright Downgrades FibroGen (FGEN) to Neutral

Apr 6, 2021 07:50 PM FibroGen Announces FDA Advisory Committee to Review Roxadustat New Drug Application Tentatively Scheduled for July 15, 2021

Apr 6, 2021 05:42 PM After-Hours Stock Movers 04/06: (NMTR) (UTME) (NCLH) Higher; (FGEN) (FIXX) (PHR) Lower (more...)

Apr 6, 2021 05:00 PM Form 8-K FIBROGEN INC For: Apr 06

Apr 6, 2021 04:04 PM FibroGen (FGEN) provided clarification of certain prior disclosures of U.S. primary cardiovascular safety analyses from roxadustat Phase 3 program for the treatment of anemia of CKD

Apr 6, 2021 04:01 PM FibroGen Provides Additional Information on Roxadustat

Mar 31, 2021 06:07 AM BofA Securities Upgrades FibroGen (FGEN) to Buy

Mar 29, 2021 01:38 PM Form SEC STAFF LETTER FIBROGEN INC

Mar 29, 2021 01:37 PM Form SEC STAFF LETTER FIBROGEN INC

Mar 16, 2021 07:08 AM FibroGen (FGEN) Begins LELANTOS-2, a Second Phase 3 Clinical Study of Pamrevlumab for Treatment of DMD

Mar 16, 2021 07:00 AM FibroGen Initiates LELANTOS-2 – Second Phase 3 Clinical Study of Pamrevlumab for the Treatment of Duchenne Muscular Dystrophy

Mar 15, 2021 06:23 PM Form 4 FIBROGEN INC For: Mar 11 Filed by: KEARNS THOMAS F JR

Mar 10, 2021 05:39 PM Form 4 FIBROGEN INC For: Mar 08 Filed by: Kouchakji Elias

Mar 10, 2021 05:35 PM Form 4 FIBROGEN INC For: Mar 08 Filed by: Cotroneo Pat

Mar 10, 2021 05:33 PM Form 4 FIBROGEN INC For: Mar 08 Filed by: Chung Christine

Mar 2, 2021 09:28 AM Pre-Open Stock Movers 03/02: (INUV) (TMDX) (RKT) Higher; (FGEN) (LODE) (AI) Lower (more...)

Mar 2, 2021 06:53 AM UPDATE: Jefferies Downgrades FibroGen (FGEN) to Hold

Mar 1, 2021 05:35 PM After-Hours Stock Movers 03/01: (ZM) (PSN) (NLSN) Higher; (FGEN) (AI) (INSG) Lower (more...)

Mar 1, 2021 04:25 PM Form 10-K FIBROGEN INC For: Dec 31

Mar 1, 2021 04:07 PM Form 8-K FIBROGEN INC For: Mar 01

Mar 1, 2021 04:06 PM FibroGen (FGEN) announces FDA will hold an advisory committee meeting to review the new drug application for roxadustat

Mar 1, 2021 04:01 PM FibroGen Reports Fourth Quarter and Full Year 2020 Financial Results

Mar 1, 2021 04:01 PM FibroGen Provides Regulatory Update on Roxadustat

Feb 26, 2021 07:28 PM Form 4 FIBROGEN INC For: Feb 24 Filed by: Wettig Thane

Feb 26, 2021 07:26 PM Form 4 FIBROGEN INC For: Feb 24 Filed by: Kouchakji Elias

Feb 26, 2021 07:24 PM Form 4 FIBROGEN INC For: Feb 24 Filed by: Cotroneo Pat

Feb 26, 2021 07:21 PM Form 4 FIBROGEN INC For: Feb 24 Filed by: Chung Christine

Feb 26, 2021 07:19 PM Form 4 FIBROGEN INC For: Feb 24 Filed by: Conterno Enrique A

Feb 26, 2021 07:08 PM Form 3/A FIBROGEN INC For: Jun 22 Filed by: Wettig Thane

Feb 19, 2021 07:10 PM Form 4 FIBROGEN INC For: Feb 17 Filed by: Kurkijarvi Kalevi

Feb 18, 2021 07:00 AM FibroGen to Report Fourth Quarter and Full Year 2020 Financial Results

Feb 12, 2021 07:00 AM FibroGen to Present at Upcoming Investor Conferences

Feb 10, 2021 03:57 PM FibroGen (FGEN), Pliant Therapeutics (PLRX) to Benefit from Galapagos (GLPG)/Gilead (GILD) Discontinued ISABELA Phase 3 Trials in IPF - Citi

Feb 10, 2021 10:54 AM Form SC 13G/A FIBROGEN INC Filed by: VANGUARD GROUP INC

Feb 8, 2021 10:22 AM Form SC 13G/A FIBROGEN INC Filed by: FMR LLC

Feb 1, 2021 06:32 AM UPDATE: H.C. Wainwright Starts FibroGen (FGEN) at Buy

Jan 29, 2021 10:01 AM Form SC 13G/A FIBROGEN INC Filed by: BlackRock Inc.

Jan 27, 2021 06:00 AM Form 8-K FIBROGEN INC For: Jan 13

Jan 21, 2021 07:25 PM Form 4 FIBROGEN INC For: Jan 19 Filed by: Kurkijarvi Kalevi

Jan 15, 2021 08:03 PM Form 4 FIBROGEN INC For: Jan 14 Filed by: Kurkijarvi Kalevi

Jan 8, 2021 07:40 PM Form 4 FIBROGEN INC For: Jan 06 Filed by: Conterno Enrique A

Jan 7, 2021 10:04 AM Form SC 13G/A FIBROGEN INC Filed by: PRIMECAP MANAGEMENT CO/CA/

Jan 6, 2021 07:08 PM Form 4 FIBROGEN INC For: Jan 04 Filed by: Schoeneck James A

Dec 30, 2020 06:08 PM Form 4 FIBROGEN INC For: Dec 28 Filed by: Kurkijarvi Kalevi

Dec 22, 2020 07:02 AM FibroGen (FGEN) Reports First Patient Dosing in ZEPHYRUS-2 Phase 3 Clinical Study of Pamrevlumab in Patients with IPF